What Eye Drops Are Best for Blepharitis?

No single eye drop works best for every case of blepharitis, because the condition comes in several forms driven by different underlying problems. A drop that clears bacterial overgrowth on the lash line may do nothing for clogged oil glands deeper in the lid, and neither will help much if the real culprit is a microscopic mite infestation. The good news is that targeted options now exist for each scenario, and the evidence behind them has sharpened considerably in recent years.

Why the Type of Blepharitis Matters

Blepharitis broadly splits into anterior and posterior forms. Anterior blepharitis involves the outer edge of the eyelid near the lash roots, usually driven by bacterial colonization or dandruff-like skin conditions. Posterior blepharitis centers on the meibomian glands, the tiny oil-producing glands along the inner lid margin. When those glands get blocked or inflamed, you end up with meibomian gland dysfunction (MGD), which is the most common driver of posterior blepharitis. A third category, Demodex blepharitis, is caused by an overpopulation of Demodex mites burrowing into lash follicles. Many people have more than one type going on at the same time.

Despite these distinct causes, treatment strategies share common ground. Warm compresses and lid hygiene remain the foundation for all forms, and most eye drop therapies overlap between anterior and posterior disease.¹ What changes is which drops get layered on top of that baseline, and for how long.

Lubricating Eye Drops as a Starting Point

Almost everyone with blepharitis benefits from lubricating eye drops, commonly called artificial tears. They don’t treat the root cause, but they relieve the gritty, burning discomfort that makes the condition miserable day to day. If your blepharitis involves MGD, though, the type of lubricant you pick matters more than you might expect.

Standard aqueous artificial tears add moisture, but they don’t address the damaged oil layer on the tear film that MGD disrupts. Lipid-containing (sometimes called “emollient”) drops are designed to replenish that oil layer. In randomized trials, lipid-based drops outperformed aqueous ones for people with evaporative dry eye tied to MGD, and regular use appeared to increase the thickness of the lipid layer on the tear film.² One study measured a jump in lipid layer thickness of roughly 28 nanometers within 15 minutes of using an emollient drop, while a non-emollient drop produced no meaningful change.³

If your blepharitis is mostly anterior and your oil glands are functioning normally, a basic preservative-free artificial tear is probably fine. But if you notice your tears evaporate quickly or your eyes feel worse in dry or windy environments, a lipid-based formulation is worth trying first.

Antibiotic Eye Drops

When bacteria are driving the inflammation, topical antibiotics can help. A Cochrane review of 34 studies involving over 2,100 participants found that topical antibiotics provided some symptomatic relief for anterior blepharitis and were effective at clearing bacteria from the eyelid margin.⁴ Traditional options include erythromycin ointment and bacitracin applied to the lash line, though these are used more as ointments than drops.

For posterior blepharitis tied to MGD, topical azithromycin has become the antibiotic eye drop with the strongest evidence. It does more than just kill bacteria. Research suggests azithromycin has anti-inflammatory properties and may directly stimulate meibomian gland cells to produce lipids, addressing both infection and gland dysfunction at the same time.⁵ Clinical trials have shown it improves eyelid inflammation, the quality and quantity of the tear film’s lipid layer, and tear film stability.

A 2024 study testing topical azithromycin in blepharitis patients found significant improvements in lid vascularity, lid plugging, and the quality of meibomian gland secretions by day 14, with continued improvement through day 28. Among the bacteria initially cultured from patients’ eyes, roughly two-thirds were eliminated by the end of treatment, with no serious adverse events.⁶ A separate survey-based study tracked patients after azithromycin treatment and found that improvements in symptoms like light sensitivity, grittiness, and burning persisted a year later, with reduced reliance on lid wipes and artificial tears.⁷

The catch is that azithromycin eye drops are not available over the counter in most countries and typically require a prescription. Your eye doctor may prescribe it off-label or as a compounded preparation, depending on local availability.

Steroid and Anti-Inflammatory Drops

When inflammation is the dominant problem, anti-inflammatory eye drops can make a dramatic difference. Corticosteroid drops like loteprednol etabonate are commonly used for short-term flare-ups. A trial comparing loteprednol combined with tobramycin against dexamethasone combined with tobramycin for blepharitis found nearly identical improvements in composite blepharitis severity over two weeks.⁸ Loteprednol is generally preferred over stronger steroids like dexamethasone for blepharitis because it is a “soft steroid” designed to break down more quickly in the eye, which lowers the risk of the pressure increases and cataract formation associated with prolonged steroid use.

That said, steroid drops are not meant for long-term use. Even loteprednol carries some risk of elevated eye pressure if used continuously, so eye doctors typically limit courses to a few weeks and monitor intraocular pressure during treatment. For moderate to severe flare-ups, a combination of tobramycin and dexamethasone has been shown to provide faster inflammation relief than azithromycin alone in the acute phase.⁹ The trade-off is speed versus safety: combo steroid-antibiotic drops work fast on acute flares but aren’t safe enough for ongoing use.

Cyclosporine for Chronic Cases

For people whose blepharitis and associated dry eye keep coming back despite warm compresses and short steroid courses, cyclosporine A (CsA) eye drops offer a longer-term option. Cyclosporine is an immunomodulator, not a steroid, so it doesn’t carry the same pressure and cataract risks. It works by dampening the overactive immune response on the ocular surface that sustains chronic inflammation.

A study of 0.05% CsA nanoemulsion drops used alongside warm compresses found significant improvements in tear film stability, eyelid debris, and lid redness after three months compared to warm compresses alone. Meibomian gland secretion quality also improved, though the treatment could not reverse glandular loss that had already occurred.¹⁰ That last point is worth emphasizing: cyclosporine can calm inflammation and improve what your remaining glands produce, but if glands have already been destroyed by years of untreated MGD, they don’t come back. Early treatment matters.

A separate trial combining 0.05% CsA with sodium hyaluronate drops for MGD-related dry eye showed improvements in tear breakup time, Schirmer scores, and patient-reported discomfort over three months, and was effective at controlling lid margin inflammation.¹¹ A head-to-head comparison of CsA against loteprednol for chronic blepharitis found both were effective at reducing symptoms.¹² The practical difference is that CsA can be used for months or even years, while steroid drops cannot.

The main drawback of cyclosporine drops is that they sting or burn on instillation, especially during the first few weeks. This is uncomfortable enough that some people stop using them. The burning tends to fade over time as the ocular surface heals. Refrigerating the drops before use can help take the edge off.

Lotilaner for Demodex Blepharitis

If your blepharitis is driven by Demodex mites, none of the drops discussed so far will resolve the root cause. Mite-driven blepharitis typically shows up as waxy, cylindrical debris (called collarettes) clinging to the base of the eyelashes, along with redness and itching that can be persistent and frustrating. For decades, treatment options were limited to tea tree oil preparations, which work to some extent but irritate many people’s eyes.

That changed with the FDA approval of lotilaner ophthalmic solution 0.25% (brand name Xdemvy), the first prescription drop specifically designed to kill Demodex mites. Lotilaner is an antiparasitic that paralyzes and kills the mites by blocking a specific chloride channel in their nervous system. Its high lipophilicity allows it to penetrate into the lash follicles and meibomian glands where mites actually live.¹³

The clinical trial data is striking. A pooled analysis of two pivotal trials found that about half of patients on lotilaner achieved complete collarette cure (essentially zero collarettes on the upper lid) by day 43, compared to roughly 10% of those on placebo. When the bar was lowered to a clinically meaningful reduction of 10 or fewer collarettes, about 85% of lotilaner patients hit that mark. Mite eradication rates were about 60% in the treatment group versus 16% in controls, and lid redness improved significantly as well.¹⁴ Across the broader set of phase 2 and 3 trials involving 980 patients, the proportion achieving 10 or fewer collarettes ranged from 81% to 93%, and mite eradication rates ranged from 52% to 78%.¹⁵

The standard regimen is one drop in each eye twice daily for six weeks. Common side effects include mild stinging and eye redness. The bigger barrier for many patients is cost: as a newer brand-name medication, lotilaner can be expensive without insurance coverage. Still, for people who have struggled with Demodex blepharitis for years, it represents a genuinely new category of treatment.

Lifitegrast and the Inflammation Angle in MGD

Lifitegrast (Xiidra) is an anti-inflammatory drop FDA-approved for dry eye disease, but emerging evidence suggests it has a role in inflammatory MGD as well. It works by blocking a protein interaction on the surface of immune cells that drives the inflammatory cascade on the ocular surface. In an animal model, lifitegrast suppressed the specific immune cell types (TH17 cells and neutrophils) most associated with MGD severity.¹⁶

In a randomized clinical trial, lifitegrast was compared head-to-head with a thermal pulsation procedure (a device-based treatment that heats and compresses the meibomian glands). Lifitegrast improved both patient symptoms and clinical signs more than the procedure, leading the researchers to conclude that anti-inflammatory treatment should be part of MGD management when inflammation is prominent.¹⁷ This is a useful finding because it challenges the assumption that MGD is primarily a mechanical problem of blocked glands. For a subset of patients, the inflammation is the main event, and treating it directly with a drop like lifitegrast can be more effective than trying to physically unclog the glands.

Tea Tree Oil Preparations

Tea tree oil has a long history of use against Demodex blepharitis, predating lotilaner by many years. It contains terpinen-4-ol, a compound with demonstrated acaricidal (mite-killing) activity. Multiple studies have confirmed that various tea tree oil formulations, including eyelash shampoos, lid wipes, and eyelid patches, reduce Demodex counts and improve symptoms.¹⁸

The problem is consistency and tolerability. A Cochrane review examining tea tree oil for Demodex blepharitis found uncertain evidence regarding how well it works compared to other interventions at four to six weeks. Some participants experienced ocular irritation that resolved with adjusted application technique, and the review suggested that lower concentrations may be preferable to avoid that irritation.¹⁹ Products vary widely in concentration and formulation, which makes it hard to give a blanket recommendation. If you use a tea tree oil product, stick with commercially prepared lid scrubs designed for ocular use rather than applying raw tea tree essential oil, which can cause a chemical burn.

Hypochlorous Acid Lid Sprays

Hypochlorous acid (HOCl) sprays sit in a category between lid hygiene and antimicrobial drops. You spray them on closed eyelids or apply them with a cotton pad, and they work by reducing bacterial load on the lid margin. A prospective randomized study compared hypochlorous acid spray to a hyaluronic acid-based cleanser and found that hypochlorous acid reduced the total bacterial count on the lid margin by about 90%, compared to roughly 62% for the hyaluronic acid cleanser.²⁰

These sprays are available over the counter and are well tolerated. They won’t replace prescription drops for moderate or severe blepharitis, but they are a solid addition to a daily lid hygiene routine and can reduce the frequency with which you need stronger medications. Think of them as the antimicrobial upgrade to basic warm-water lid cleansing.

Preservative-Free Formulations and Why They Matter

Whichever drops you use, how often you use them matters as much as what is in them. The most common preservative in eye drops, benzalkonium chloride (BAK), is itself toxic to the cells on your eye’s surface. Lab studies have shown that BAK inhibits cellular energy production and causes cell death at concentrations far below what is typically present in commercial eye drops.²¹ Cell viability studies testing glaucoma drops found clear toxicity differences between BAK-preserved and preservative-free formulations.²²

For someone using artificial tears a few times a week, BAK is unlikely to cause noticeable harm. But blepharitis patients often use multiple drops multiple times a day, and that cumulative exposure adds up. If you are using lubricating drops more than about four times daily, or layering several different medicated drops, choosing preservative-free single-use vials wherever available is a meaningful way to protect the surface you are trying to heal.

Omega-3 Topical Drops

Oral omega-3 supplements for dry eye have received enormous attention, but topical omega-3 fatty acid eye drops are a newer idea. A systematic review of the available evidence found promising results for improving ocular surface staining and tear breakup time compared to controls. However, the evidence for improving MGD specifically and subjective symptoms was mixed, and omega-3 drops did not appear to increase tear production.²³ Animal studies showed the drops reduced inflammatory markers on the eye’s surface, which is encouraging, but the human data isn’t strong enough yet to make topical omega-3 drops a clear recommendation for blepharitis. They are worth watching as the research matures, but not worth prioritizing over the better-established options.

Fitting Drops Into the Bigger Treatment Picture

Eye drops work best when they are part of a layered approach rather than the only thing you are doing. Warm compresses soften hardened meibomian gland secretions and allow the glands to drain. Lid massage after warming helps express that material. Lid hygiene with a gentle cleanser or hypochlorous acid spray reduces bacterial and mite populations. Drops then address whatever the compresses and hygiene cannot resolve on their own.

In-office procedures can amplify what drops accomplish. Intense pulsed light (IPL) therapy uses light energy to reduce lid margin inflammation and kill Demodex, while thermal pulsation devices like LipiFlow physically heat and compress the meibomian glands to clear blockages more thoroughly than at-home warm compresses can manage.²⁴ These aren’t substitutes for daily drop use in most cases, but they can break a cycle of chronic disease that drops alone haven’t been able to control.

A practical sequence for someone newly diagnosed might look like this: start with preservative-free lipid-based lubricating drops and twice-daily warm compresses with lid hygiene. If symptoms persist after a month, see your eye doctor about adding a prescription drop, whether that’s topical azithromycin for MGD, cyclosporine for chronic inflammation, or lotilaner if Demodex is identified. Short steroid courses can bridge the gap during acute flares while slower-acting treatments like cyclosporine ramp up. The specific combination depends on which type of blepharitis you have and how your eyes respond, which is why a proper evaluation matters more than grabbing the first bottle off the pharmacy shelf.